Humoral hypercalcaemia of malignancy associated with a gigantic cutaneous squamous cell carcinoma

BMJ Case Rep. 2022 Nov 2;15(11):e250598. doi: 10.1136/bcr-2022-250598.

Abstract

Humoral hypercalcaemia of malignancy is rarely associated with cutaneous squamous cell carcinoma (SCC), and only a few cases have been reported in the medical literature. We present an interesting case of a gigantic cutaneous SCC associated with severe hypercalcaemia.A man in his mid 80s presented with a rapidly enlarging fungating mass of his scalp for 5 months. Laboratory studies logged severe hypercalcaemia, low intact parathyroid hormone, elevated parathyroid hormone related-peptide and normal 1,25 dihydroxy vitamin D. Skin biopsy revealed moderately differentiated invasive SCC. Further workup was negative for distant skeletal metastases. Severe hypercalcaemia was managed by intravenous fluids, bisphosphonates and calcitonin. A multidisciplinary approach was then made; the patient received radiotherapy and then underwent a successful surgical resection. By presenting this case, we aim to raise physicians' awareness of the association between cutaneous SCC and hypercalcaemia. Severe hypercalcaemia should be detected early and promptly managed as it could be fatal.

Keywords: calcium and bone; skin cancer.

Publication types

  • Case Reports

MeSH terms

  • Carcinoma, Squamous Cell* / complications
  • Diphosphonates / therapeutic use
  • Humans
  • Hypercalcemia* / etiology
  • Male
  • Parathyroid Hormone
  • Skin Neoplasms* / complications

Substances

  • Parathyroid Hormone
  • Diphosphonates